Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sex Characteristics | 4 | 2022 | 2510 | 1.170 |
Why?
|
Purinergic P2Y Receptor Antagonists | 2 | 2017 | 343 | 1.030 |
Why?
|
Exercise Tolerance | 6 | 2021 | 802 | 1.010 |
Why?
|
Sex Factors | 9 | 2022 | 10566 | 1.000 |
Why?
|
Heart Failure | 12 | 2022 | 10040 | 0.980 |
Why?
|
Pulmonary Edema | 2 | 2021 | 418 | 0.840 |
Why?
|
Early Termination of Clinical Trials | 1 | 2021 | 69 | 0.830 |
Why?
|
Stroke Volume | 10 | 2022 | 4522 | 0.800 |
Why?
|
Pheochromocytoma | 1 | 2021 | 339 | 0.710 |
Why?
|
Drug Therapy | 1 | 2021 | 518 | 0.660 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2018 | 183 | 0.610 |
Why?
|
Infertility | 1 | 2022 | 565 | 0.580 |
Why?
|
Mitral Valve Stenosis | 1 | 2018 | 382 | 0.580 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 731 | 0.570 |
Why?
|
Inflammation Mediators | 2 | 2022 | 1948 | 0.570 |
Why?
|
Blood Coagulation Disorders | 1 | 2018 | 341 | 0.560 |
Why?
|
Women | 1 | 2016 | 224 | 0.520 |
Why?
|
Blood Proteins | 1 | 2019 | 1144 | 0.520 |
Why?
|
Menopause | 1 | 2022 | 1518 | 0.510 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2018 | 511 | 0.490 |
Why?
|
Muscle Fatigue | 1 | 2013 | 81 | 0.490 |
Why?
|
Respiratory Muscles | 1 | 2013 | 138 | 0.480 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1928 | 0.480 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 103 | 0.480 |
Why?
|
Cardiovascular Diseases | 4 | 2022 | 14075 | 0.480 |
Why?
|
Albuterol | 1 | 2013 | 211 | 0.460 |
Why?
|
Acidosis, Lactic | 1 | 2013 | 128 | 0.460 |
Why?
|
Blood Coagulation | 1 | 2018 | 1114 | 0.450 |
Why?
|
Physicians, Women | 1 | 2018 | 471 | 0.440 |
Why?
|
Exercise Test | 6 | 2022 | 2125 | 0.430 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2021 | 274 | 0.390 |
Why?
|
Proteomics | 2 | 2022 | 3244 | 0.370 |
Why?
|
Hypertension | 4 | 2021 | 8161 | 0.350 |
Why?
|
Obesity | 5 | 2021 | 12031 | 0.340 |
Why?
|
Myocardium | 1 | 2021 | 4969 | 0.320 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3316 | 0.310 |
Why?
|
Cardiology | 1 | 2018 | 1638 | 0.310 |
Why?
|
Cardiomyopathies | 1 | 2018 | 1819 | 0.310 |
Why?
|
Phenotype | 2 | 2021 | 16306 | 0.300 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 1832 | 0.300 |
Why?
|
Inflammation | 3 | 2021 | 10019 | 0.270 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6213 | 0.250 |
Why?
|
Risk Factors | 11 | 2022 | 69553 | 0.250 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3439 | 0.240 |
Why?
|
Anticoagulants | 1 | 2018 | 4293 | 0.240 |
Why?
|
Hemodynamics | 4 | 2021 | 4211 | 0.230 |
Why?
|
Ventricular Function, Left | 4 | 2022 | 3411 | 0.230 |
Why?
|
Hematemesis | 1 | 2021 | 25 | 0.210 |
Why?
|
Hierarchy, Social | 1 | 2021 | 21 | 0.210 |
Why?
|
Female | 26 | 2022 | 375205 | 0.210 |
Why?
|
Leptospirosis | 1 | 2021 | 30 | 0.210 |
Why?
|
Middle Aged | 18 | 2022 | 213752 | 0.200 |
Why?
|
Humans | 34 | 2022 | 708843 | 0.200 |
Why?
|
Blood Sedimentation | 1 | 2020 | 237 | 0.190 |
Why?
|
C-Reactive Protein | 3 | 2021 | 3696 | 0.190 |
Why?
|
Hemoptysis | 1 | 2021 | 149 | 0.190 |
Why?
|
Insulin Resistance | 4 | 2021 | 3866 | 0.190 |
Why?
|
Risk Reduction Behavior | 2 | 2017 | 1110 | 0.190 |
Why?
|
Verbal Behavior | 1 | 2021 | 345 | 0.180 |
Why?
|
Male | 24 | 2022 | 349524 | 0.180 |
Why?
|
Atrial Function, Right | 1 | 2018 | 36 | 0.180 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 445 | 0.170 |
Why?
|
Pulmonary Gas Exchange | 1 | 2020 | 376 | 0.170 |
Why?
|
Adipokines | 1 | 2020 | 298 | 0.160 |
Why?
|
Cardiac Volume | 1 | 2018 | 214 | 0.160 |
Why?
|
Electrocardiography | 3 | 2022 | 6386 | 0.160 |
Why?
|
Adiponectin | 2 | 2021 | 1081 | 0.160 |
Why?
|
Lung | 3 | 2021 | 9706 | 0.160 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1673 | 0.150 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 815 | 0.150 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 497 | 0.150 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 591 | 0.150 |
Why?
|
Fatal Outcome | 1 | 2021 | 1887 | 0.150 |
Why?
|
Aged | 12 | 2022 | 161488 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 577 | 0.140 |
Why?
|
Leptin | 2 | 2021 | 1572 | 0.140 |
Why?
|
Logistic Models | 2 | 2021 | 13468 | 0.140 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11323 | 0.140 |
Why?
|
Radiography, Thoracic | 1 | 2021 | 1344 | 0.130 |
Why?
|
Patient Preference | 1 | 2021 | 856 | 0.120 |
Why?
|
Internal Medicine | 1 | 2021 | 1007 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2021 | 3179 | 0.120 |
Why?
|
Health Services Research | 1 | 2021 | 1836 | 0.120 |
Why?
|
Women's Health | 1 | 2022 | 1898 | 0.120 |
Why?
|
Severity of Illness Index | 2 | 2021 | 16008 | 0.110 |
Why?
|
Dyspnea | 1 | 2020 | 1237 | 0.110 |
Why?
|
Heart Atria | 1 | 2018 | 1286 | 0.110 |
Why?
|
Linear Models | 2 | 2020 | 5986 | 0.110 |
Why?
|
Adiposity | 1 | 2021 | 1734 | 0.110 |
Why?
|
Massachusetts | 2 | 2021 | 8712 | 0.100 |
Why?
|
Administration, Inhalation | 1 | 2013 | 1102 | 0.100 |
Why?
|
Outpatients | 1 | 2018 | 1349 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 863 | 0.100 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1331 | 0.100 |
Why?
|
Adult | 13 | 2021 | 211041 | 0.100 |
Why?
|
Quality of Life | 2 | 2022 | 11594 | 0.100 |
Why?
|
Adipose Tissue | 1 | 2022 | 3234 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1489 | 0.090 |
Why?
|
Education, Medical | 1 | 2021 | 1683 | 0.090 |
Why?
|
Blood Pressure | 2 | 2022 | 8528 | 0.090 |
Why?
|
Pregnancy | 2 | 2022 | 26832 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1572 | 0.090 |
Why?
|
Echocardiography | 2 | 2018 | 5139 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2018 | 2653 | 0.080 |
Why?
|
Curriculum | 1 | 2021 | 3329 | 0.080 |
Why?
|
Prospective Studies | 6 | 2022 | 50597 | 0.080 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1365 | 0.080 |
Why?
|
Treatment Outcome | 5 | 2022 | 61932 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2017 | 2964 | 0.070 |
Why?
|
Coronary Angiography | 1 | 2017 | 4383 | 0.070 |
Why?
|
Registries | 1 | 2021 | 7989 | 0.070 |
Why?
|
Hospitalization | 2 | 2021 | 9644 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 2994 | 0.070 |
Why?
|
Mortality | 1 | 2016 | 2732 | 0.070 |
Why?
|
Prognosis | 2 | 2022 | 28919 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6497 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5348 | 0.060 |
Why?
|
Internship and Residency | 1 | 2021 | 5556 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2021 | 210 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9488 | 0.050 |
Why?
|
Bundle-Branch Block | 1 | 2022 | 276 | 0.050 |
Why?
|
Mexico | 1 | 2021 | 673 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3014 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15252 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15053 | 0.040 |
Why?
|
Videoconferencing | 1 | 2021 | 190 | 0.040 |
Why?
|
Communication Barriers | 1 | 2021 | 364 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 13274 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 409 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 23950 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23284 | 0.040 |
Why?
|
Odds Ratio | 2 | 2020 | 9754 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2021 | 777 | 0.040 |
Why?
|
Bronchoscopy | 1 | 2021 | 842 | 0.030 |
Why?
|
Travel | 1 | 2021 | 726 | 0.030 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 475 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2021 | 1446 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1280 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1055 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1588 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1121 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 15538 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39038 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2144 | 0.030 |
Why?
|
Incidence | 2 | 2022 | 20320 | 0.030 |
Why?
|
Body Mass Index | 2 | 2020 | 12366 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1817 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3562 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2564 | 0.020 |
Why?
|
Cholesterol | 1 | 2018 | 2866 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2176 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5095 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2758 | 0.020 |
Why?
|
Exercise | 1 | 2022 | 5251 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58184 | 0.020 |
Why?
|
Blood Glucose | 1 | 2018 | 6255 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12292 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3885 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 6991 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3934 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 55940 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 14712 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 4454 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 39292 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20308 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 41038 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 84718 | 0.010 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_